Group 1 - The board of directors of Shenzhen Huakong Saige Co., Ltd. held its 20th temporary meeting on January 26, 2026, via telecommunication voting, with all 9 directors participating [2][4] - The meeting was legally valid and complied with the relevant provisions of the Company Law of the People's Republic of China and the company's articles of association [2] - The board reviewed the proposal for the 2025 annual performance forecast, with details to be published in a separate announcement [3] Group 2 - The company anticipates a net loss for the year 2025, with the performance forecast period from January 1, 2025, to December 31, 2025 [7] - The expected loss of 50 million yuan is primarily due to a dispute related to a contract with the government of Qitaihe City, resulting in a provision for potential liabilities [8] - The company reported a decrease in profit attributable to shareholders compared to the previous year, influenced by the absence of a similar one-time profit recorded in 2024 [8]

Group 1 - The company expects a negative net profit for the fiscal year 2025, covering the period from January 1, 2025, to December 31, 2025 [1] - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies between the two parties [1] - The decline in operating income is attributed to market fluctuations and reforms in the DRG payment policy, leading to a decrease in revenue compared to the previous year [1] Group 2 - The company is implementing measures to adjust its business structure and improve operational efficiency, which has resulted in a narrowing of losses in the fourth quarter [1] - Despite these efforts, the total scale of operating income has not yet covered operational costs and period expenses [1]

Core Viewpoint - The company expects a significant decline in net profit for the year 2025, projecting a decrease of 62.29% to 70.23% compared to the previous year, despite an increase in sales volume of broiler chicks [1][2]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an expected net profit in the range of 15 million to 19 million yuan [1][2]. - The company anticipates a decline in net profit of over 50% compared to the previous year [1]. Group 2: Sales and Pricing Dynamics - The sales volume of broiler chicks increased by over 10% year-on-year, but the average selling price significantly dropped, leading to a temporary loss in this segment [1]. - Starting from September 2025, the price of parent broiler chicks has been rising monthly due to improved market conditions and tight supply of quality breeding stock [2]. Group 3: Business Growth Areas - The company's pig breeding business experienced explosive growth, with sales reaching 98,400 heads, a year-on-year increase of 228.43%, becoming a key profit driver [2]. - The company aims to enhance operational efficiency through refined management practices and cost control while expanding its broiler chicken scale and accelerating pig breeding capacity [2].

Core Viewpoint - The company, Shenzhen Hekeda Precision Cleaning Equipment Co., Ltd., anticipates a positive net profit for the fiscal year 2025, marking a turnaround from previous losses, driven by increased revenue from its cleaning equipment and wiring harness businesses [2][3][13]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an expected net profit indicating a turnaround situation [2]. - The company estimates a net profit range of 15.5 million to 21 million yuan and a net profit (excluding non-recurring gains and losses) range of 8 million to 12 million yuan for 2025 [13]. - Expected operating revenue for 2025 is projected to be between 260 million and 334 million yuan, with the revenue excluding unrelated business income estimated between 240 million and 328 million yuan [13]. Group 2: Revenue Growth Drivers - Revenue growth is attributed to an increase in orders for cleaning equipment and wiring harnesses, along with the completion of prior water treatment projects [3][13]. - The optimization of profit structure is supported by a higher proportion of orders from overseas end customers, which has improved profitability [3]. Group 3: Financial Health Improvement - The company expects significant non-recurring gains to positively impact net profit, primarily due to the full recovery of previously restructured debts and the reversal of some credit impairment losses [3]. - The overall asset quality has improved, providing additional support for net profit growth [3]. Group 4: Risk of Delisting - The company has been under a delisting risk warning since April 30, 2025, due to previous financial performance issues, specifically a negative net profit in 2024 [11][12]. - If the company fails to meet specific financial criteria in 2025, including a negative net profit or insufficient operating revenue, it risks being delisted [12][13].

Group 1 - The company expects a positive net profit for the year 2025, with an increase of over 50% compared to the previous year [1] - The company has communicated with the auditing firm regarding the financial data for the 2025 performance forecast, and there are currently no discrepancies [1] - The company has optimized its product and business structure, leading to a slight decrease in total revenue compared to 2024, while maintaining growth in net profit and improving profitability [1][2] Group 2 - The revenue from digital cost business has slightly decreased, but the renewal rate has shown steady improvement [1] - The strategic focus on digital construction business has yielded results, with revenue growth and improved gross margin [1] - The company's internationalization efforts are progressing steadily, resulting in rapid growth in overseas revenue [1]

3.业绩预告情况表 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000516 证券简称：国际医学 公告编号：2026-004 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1.业绩预告期间：2025年1月1日至2025年12月31日 2.业绩预告情况：预计净利润为负值 本次业绩预告是公司财务部门进行初步测算后的预计，未经审计机构审计。具体财务数据将在公司2025 年度报告中详细披露。敬请广大投资者注意投资风险。 特此公告。 西安国际医学投资股份有限公司董事会 二〇二六年一月二十七日 二、与会计师事务所沟通情况 本次业绩预告未经注册会计师预审计。公司就本次业绩预告与为公司提供年度审计服务的会计师事务所 签字注册会计师进行了预沟通，双方在本次业绩预告方面不存在分歧。 三、业绩变动原因说明 报告期内，公司受市场波动、DRG支付政策改革等行业动态调整影响，营业收入同比下降。公司采取 调整业务结构，实施降本增效等措施并持续改善经营成效，第四季度亏损幅度收窄，但营业收入总规模 尚未能覆盖运营成本和期间费用。 四、风险提示 ...

Group 1 - The company expects a positive net profit for the fiscal year 2025, indicating a turnaround from previous losses [2] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The financial data related to this performance forecast has not been audited by registered accountants, but there are no discrepancies between the company and the accounting firm regarding the forecast [2] Group 2 - The main reasons for the performance change include significant growth in revenue driven by successful development of core clients [3] - The product structure has been continuously optimized, with increased sales of high-value products such as starry tents and their accessories, contributing to improved overall profitability [3] - Enhanced operational efficiency has been achieved through refined management practices, leading to effective control of sales and management expenses [4]

Group 1 - The company expects a net profit loss for the fiscal year 2025, with the performance period from January 1, 2025, to December 31, 2025 [1] - The preliminary financial data for the performance forecast has not been audited by the accounting firm, but there are no significant disagreements between the company and the auditors regarding the forecast [1][2] Group 2 - The decline in performance is attributed to intense competition in the radio frequency device industry, leading to significant price pressure from customers and an increasing proportion of low-margin products [2] - The prices of bulk metal raw materials required for production have risen sharply during the reporting period, which the company has been unable to fully offset despite efforts to reduce costs and improve efficiency [2]

证券代码：688071 证券简称：华依科技（维权） 公告编号：2026-004 上海华依科技集团股份有限公司 2025年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （二）业绩预告情况 四、风险提示 1、经财务部门初步测算，预计2025年度实现归属于母公司所有者的净利润为-5,350万元到-6,400万元。 2、预计2025年归属于母公司所有者的扣除非经常性损益后的净利润为-5,631.16万元到-6,681.16万元。 （三）本次业绩预告未经注册会计师审计。 二、上年同期业绩情况 2024年度，公司实现营业收入42,343.52万元，利润总额-6,411.78万元，归属于母公司所有者的净利 润-4,673.70万元，归属于母公司所有者的扣除非经常性损益的净利润-5,054.20万元，每股收益-0.55元。 三、本期业绩变化的主要原因 本期测试服务实验室等相继投入使用，固定成本（如折旧）增加，且新产能释放需要过程，对当期收入 贡献有限，导致毛利同比下降。受汽车行业竞争加剧影响，本期部分 ...

Group 1 - The company expects a positive net profit for the fiscal year 2025, indicating a turnaround from previous losses [1] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The company anticipates a decrease in revenue from small household appliances by approximately 12% to 16% compared to the previous year, while LED packaging revenue is expected to decline by about 6% to 8% due to reduced overseas orders and increased competition [1] Group 2 - The company has communicated with its auditing firm regarding the performance forecast, and there are no significant disagreements [1] - The expected impact of ongoing business operations on net profit attributable to shareholders is estimated to be a loss of approximately RMB -68 million to -95 million, which is a reduction in loss of about RMB 62 million to 35 million compared to the previous year, narrowing the loss margin by approximately 27% to 47% [1] - The company anticipates a negative impact on net profit from the termination of its LED business, with expected losses of about RMB -47 million to -65 million due to depreciation and impairment of related assets [2] Group 3 - Non-recurring gains are expected to positively impact net profit by approximately RMB 155 million to 175 million, primarily from the disposal of idle assets in Dalian and the gradual settlement of historical debts [2]